Advancing Point-of-Care Applications with Droplet Microfluidics: From Single-Cell to Multicellular Analysis.

Christina Sharkey1,2, Rachel White1, Michael Finocchiaro1

  • 1Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA;

Summary

Microfluidic technologies offer advanced tools for cancer research, enabling detailed study of cancer-immune cell interactions and immunotherapy effectiveness. These methods provide insights into tumor biology and immune responses for potential point-of-care applications.